These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Exempt 2021-001329-29 A Multicenter, Open-Label, Phase I/II Study of EOS884448 in combination with standard of care and/or investigational therapies in participants with advanced solid tumors not-yet-due
Exempt 2021-004137-36 Study of EOS884448 alone, and in combination with iberdomide with or without dexamethasone, in participants with relapsed or refractory multiple myeloma 2023-12-05 not-yet-due
Ongoing 2021-005487-22 A randomized, double-blind, placebo-controlled, Phase 2 study evaluating efficacy and safety of inupadenant in combination with carboplatin and pemetrexed in adults with nonsquamous non-small cell lun... not-yet-due